Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05576974 |
|---|---|
| Brief Title: | A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) |
| First Submitted : | October 5, 2022 |
| First Submitted that Met QC Criteria : | October 8, 2022 |
| First Posted : | October 13, 2022 |
| Last Update Submitted that Met QC Criteria : | May 8, 2024 |
| Last Update Posted : | May 9, 2024 |